This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reed, J. A. Articles by Medrano, E. E. Search for Related Content PubMed PubMed Citation Articles by Reed, J. A. Articles by Medrano, E. E.

Cytoplasmic Localization of the Oncogenic Protein Ski in Human Cutaneous Melanomas in Vivo

Functional Implications for Transforming Growth Factor ß Signaling¹

Departments of Dermatology [J. A. R., E. E. M.] and Pathology [J. A. R.], and Huffington Center on Aging and Department of Molecular and Cellular Biology [E. B., W. X., N. A. O., D. B., E. E. M.], Baylor College of Medicine, Houston, Texas 77030

The oncogenic protein Ski associates with Smad proteins and counteracts their activation of gene expression and growth inhibition in response to transforming growth factor ß (TGF-ß). Here we show that Ski protein levels are increased in all 44 human melanoma tumor tissues analyzed in vivo. In addition, Ski subcellular localization changes from nuclear, in preinvasive melanomas (melanomas in situ), to nuclear and cytoplasmic in primary invasive and metastatic melanomas. Furthermore, Ski/Smad association in the cytoplasm seems to prevent Smad3 nuclear translocation in response to TGF-ß. The biological significance of Ski overexpression in melanomas was established by showing that down-regulation of Ski levels, by antisense Ski vectors, restored TGF-ß-mediated growth inhibition. Such inhibition is apparently mediated by up-regulation of the cyclin-dependent kinase-I p21^Waf-1 and inhibition of cyclin-dependent kinase 2 activity. Our results suggest that high levels of Ski in human melanomas produce a disruption of TGF-ß signaling phenotypically similar to that in cells harboring mutations in TGF-ß receptors or Smad proteins, and this may represent a significant event in the progression of melanomas in vivo.

This article has been cited by other articles:

				M. Takahata, Y. Inoue, H. Tsuda, I. Imoto, D. Koinuma, M. Hayashi, T. Ichikura, T. Yamori, K. Nagasaki, M. Yoshida, et al. SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-{beta} Signal in Gastric Cancer Cells J. Biol. Chem., January 30, 2009; 284(5): 3334 - 3344. [Abstract] [Full Text] [PDF]

				E. Le Scolan, Q. Zhu, L. Wang, A. Bandyopadhyay, D. Javelaud, A. Mauviel, L. Sun, and K. Luo Transforming Growth Factor-{beta} Suppresses the Ability of Ski to Inhibit Tumor Metastasis by Inducing Its Degradation Cancer Res., May 1, 2008; 68(9): 3277 - 3285. [Abstract] [Full Text] [PDF]

				M. B. Fuertes, M. V. Girart, L. L. Molinero, C. I. Domaica, L. E. Rossi, M. M. Barrio, J. Mordoh, G. A. Rabinovich, and N. W. Zwirner Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity J. Immunol., April 1, 2008; 180(7): 4606 - 4614. [Abstract] [Full Text] [PDF]

				W. R. Dayton and M. E. White Cellular and molecular regulation of muscle growth and development in meat animals J Anim Sci, April 1, 2008; 86(14_suppl): E217 - E225. [Abstract] [Full Text] [PDF]

				Y. Nagano, K. J. Mavrakis, K. L. Lee, T. Fujii, D. Koinuma, H. Sase, K. Yuki, K. Isogaya, M. Saitoh, T. Imamura, et al. Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-beta Signaling J. Biol. Chem., July 13, 2007; 282(28): 20492 - 20501. [Abstract] [Full Text] [PDF]

				D. Javelaud, K. S. Mohammad, C. R. McKenna, P. Fournier, F. Luciani, M. Niewolna, J. Andre, V. Delmas, L. Larue, T. A. Guise, et al. Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis Cancer Res., March 1, 2007; 67(5): 2317 - 2324. [Abstract] [Full Text] [PDF]

				M. Nagata, K. Goto, S. Ehata, N. Kobayashi, M. Saitoh, H. Miyoshi, T. Imamura, K. Miyazawa, and K. Miyazono Nuclear and cytoplasmic c-Ski differently modulate cellular functions Genes Cells, November 1, 2006; 11(11): 1267 - 1280. [Abstract] [Full Text] [PDF]

				A. R. Krakowski, J. Laboureau, A. Mauviel, M. J. Bissell, and K. Luo From the Cover: Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-{beta} signaling by sequestration of the Smad proteins PNAS, August 30, 2005; 102(35): 12437 - 12442. [Abstract] [Full Text] [PDF]

				D. S. Wilkinson, S. K. Ogden, S. A. Stratton, J. L. Piechan, T. T. Nguyen, G. A. Smulian, and M. C. Barton A Direct Intersection between p53 and Transforming Growth Factor {beta} Pathways Targets Chromatin Modification and Transcription Repression of the {alpha}-Fetoprotein Gene Mol. Cell. Biol., February 1, 2005; 25(3): 1200 - 1212. [Abstract] [Full Text] [PDF]

				N. Ueki, L. Zhang, and M. J. Hayman Ski Negatively Regulates Erythroid Differentiation through Its Interaction with GATA1 Mol. Cell. Biol., December 1, 2004; 24(23): 10118 - 10125. [Abstract] [Full Text] [PDF]

				M. Garcia, N. I. Fernandez-Garcia, V. Rivas, M. Carretero, M. J. Escamez, A. Gonzalez-Martin, E. E. Medrano, O. Volpert, J. L. Jorcano, B. Jimenez, et al. Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor Cancer Res., August 15, 2004; 64(16): 5632 - 5642. [Abstract] [Full Text] [PDF]

				A. Baldwin, L. Pirisi, and K. E. Creek NFI-Ski Interactions Mediate Transforming Growth Factor {beta} Modulation of Human Papillomavirus Type 16 Early Gene Expression J. Virol., April 15, 2004; 78(8): 3953 - 3964. [Abstract] [Full Text] [PDF]

				M. Takeda, M. Mizuide, M. Oka, T. Watabe, H. Inoue, H. Suzuki, T. Fujita, T. Imamura, K. Miyazono, and K. Miyazawa Interaction with Smad4 Is Indispensable for Suppression of BMP Signaling by c-Ski Mol. Biol. Cell, March 1, 2004; 15(3): 963 - 972. [Abstract] [Full Text] [PDF]

				D. Chen, W. Xu, E. Bales, C. Colmenares, M. Conacci-Sorrell, S. Ishii, E. Stavnezer, J. Campisi, D. E. Fisher, A. Ben-Ze'ev, et al. SKI Activates Wnt/{beta}-Catenin Signaling in Human Melanoma Cancer Res., October 15, 2003; 63(20): 6626 - 6634. [Abstract] [Full Text] [PDF]

				F. Zhang, M. Lundin, A. Ristimaki, P. Heikkila, J. Lundin, J. Isola, H. Joensuu, and M. Laiho Ski-related novel protein N (SnoN), a Negative Controller of Transforming Growth Factor-{beta} Signaling, Is a Prognostic Marker in Estrogen Receptor-positive Breast Carcinomas , Cancer Res., August 15, 2003; 63(16): 5005 - 5010. [Abstract] [Full Text] [PDF]

				J. He, S. B. Tegen, A. R. Krawitz, G. S. Martin, and K. Luo The Transforming Activity of Ski and SnoN Is Dependent on Their Ability to Repress the Activity of Smad Proteins J. Biol. Chem., August 15, 2003; 278(33): 30540 - 30547. [Abstract] [Full Text] [PDF]

				C. Prunier, M. Pessah, N. Ferrand, S. R. Seo, P. Howe, and A. Atfi The Oncoprotein Ski Acts as an Antagonist of Transforming Growth Factor-{beta} Signaling by Suppressing Smad2 Phosphorylation J. Biol. Chem., July 3, 2003; 278(28): 26249 - 26257. [Abstract] [Full Text] [PDF]

				K. Kokura, H. Kim, T. Shinagawa, M. M. Khan, T. Nomura, and S. Ishii The Ski-binding Protein C184M Negatively Regulates Tumor Growth Factor-{beta} Signaling by Sequestering the Smad Proteins in the Cytoplasm J. Biol. Chem., May 23, 2003; 278(22): 20133 - 20139. [Abstract] [Full Text] [PDF]

				M. Pessah, J. Marais, C. Prunier, N. Ferrand, F. Lallemand, A. Mauviel, and A. Atfi c-Jun Associates with the Oncoprotein Ski and Suppresses Smad2 Transcriptional Activity J. Biol. Chem., August 2, 2002; 277(32): 29094 - 29100. [Abstract] [Full Text] [PDF]